Nicole Fawcett
Director of Communications, University of Michigan Rogel Cancer
Fawcett leads a team of communicators who produce targeted, innovative communication for the Rogel Cancer Center’s research and clinical enterprises. Prior to Michigan Medicine, Fawcett was a reporter at the Detroit News and editor for a web-based community for people with disabilities.
Health Lab
The Best Treatment for Laryngeal Cancer? This Approach Helps Decide
Laryngeal cancer treatments include chemoradiation & surgery. U-M oncology team offers an approach for deciding between chemotherapy & radiation and surgery.
Health Lab
Half of Breast Cancer Patients Experience Severe Side Effects
93 percent of early stage breast cancer patients experience cancer treatment side effects. See the survey results & common breast cancer treatment side effects.
Health Lab
Study Challenges Potential Pancreatic Cancer Target
Study shows inhibiting the PDX1 protein stops pancreatic cancer growth, but makes the cancer more aggressive. Learn more about this pancreatic cancer treatment.
Health Lab
Can the Cancer Moonshot Work? Complicated Factors Are in Orbit
President Obama's Cancer Moonshot program helps fund cancer prevention, diagnosis & treatment. See what doctors believe it will take to finally cure cancer.
Health Lab
Prostate Cancer Treatment Rates Drop, Reflecting Change in Screening Recommendations
Prostate cancer screenings have dropped, but prostate cancer treatment remains high. Learn more about the overdiagnosis and overtreatment of prostate cancer.
Health Lab
Diet Could Help Breast Cancer Survivors Beat Fatigue
U-M Study finds that eating fruits, vegetables, & grains helps breast cancer survivors reduce cancer-related fatigue. See the breast cancer diet from the study.
Health Lab
Researchers Find Key Genetic Driver for Rare Type of Triple-Negative Breast Cancer
U-M researchers discovered removing the protein CCN6 from mice caused metaplastic breast cancer. Find out what this means for future breast cancer research.
Health Lab
Study Finds ‘Striking’ Use of Double Mastectomy
One in six early stage breast cancer patients choose double mastectomy. Learn about unnecessary bilateral mastectomy and why patients choose to have it.
Health Lab
Predicting Throat Cancer Recurrence with a Blood Test
U-M study finds biomarkers that may signal throat cancer recurrence. Learn how the ratio of E7 antibodies may help predict oropharyngeal cancer recurrence.
Health Lab
More Complications, Less Satisfaction in Breast Cancer Patients Who Have Radiation and Implants
A study on breast reconstruction after radiation therapy compares implant reconstruction to autologous reconstruction. Lean more about this breast cancer study.
Health Lab
Going Beyond Genetics Yields Clues to Challenging Childhood Brain Cancer
New research finds 80 percent of pediatric hindbrain ependymomas had reduced levels of H3K27me3. See how this discovery could help treat childhood brain tumors.
Medicine at Michigan
Forbes’ $17.5 million gift to stimulate cancer research
A $17.5 million gift establishes the Forbes Institute for Cancer Discovery
Health Lab
Why So Many Promising New Cancer Drugs Fail in Clinical Trials
49 out of 50 new cancer drugs fail cancer clinical trials. See why a U-M oncologist believes the oncology clinical trial failure rate is so high.
Health Lab
New Target Could Halt Growth and Spread of Ovarian Cancer
Researchers have shown the EGFL6 protein helps ovarian cancer spread. Learn more about ovarian cancer treatment and prevention using EGFL6-blocking antibodies.
Health Lab
Precision Medicine Test for Breast Cancer Helps Guide Chemotherapy Decisions
Learn how oncologists are personalizing breast cancer treatment, including whether or not chemotherapy is used, based on the 21 gene recurrence score assay test.
